Lexicon Pharmaceuticals Inc (LXRX)

0.7578 -0.07 (-8.37%) USD  |  NASDAQ  |  Dec 24, 16:00
0.7645 +0.01 (+0.88%) After-Hours: 04:32
More

Lexicon Pharmaceuticals Research and Development Expense (Quarterly): 25.78M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for LXRX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Viatris Inc 198.40M
Halozyme Therapeutics Inc 18.46M
Perspective Therapeutics Inc 12.03M
Quanterix Corp 8.104M
Autonomix Medical Inc 1.174M